Loading company…
MeMed Diagnostics, Ltd. makes FDA-cleared immune response tests that help distinguish bacterial from viral infections.
Founded in 2009 in Tirat Carmel, Israel, MeMed sells diagnostic products, including MeMed BV and the MeMed Key platform, mainly to hospitals and pediatric departments in the United States, Europe and Israel. Co-founders Eran Eden and Kfir Oved lead the company, with Eran Eden as CEO. In January 2022 it raised USD 93.00 mn in venture funding led by Horizons Ventures across 8 funding deals. Its recorded stage is Series C.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in